Company news
Onward Medical N.v. (EURONEXT:ONWD) news
Every Onward Medical N.v. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
ONWARD Medical Reports First Quarter 2026 Results with Strong Commercial Momentum and Key Clinical Milestones
May 26, 2026
ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026
May 19, 2026
ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders
May 13, 2026
ONWARD Medical Successfully Raises over EUR 40 Million in Capital Increase
April 16, 2026
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 40 Million
April 15, 2026
ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions
April 1, 2026
ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline M...
March 31, 2026
ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update
March 23, 2026
ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instabilit...
February 4, 2026
ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer
January 23, 2026
ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thoug...
January 22, 2026
ONWARD Medical delivers spinal cord stimulation systems in Europe
January 5, 2026
ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025
November 24, 2025
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
November 17, 2025
ONWARD Medical N : ONWARD Medical Publishes Closing of Bookbuild Offering
October 29, 2025
ONWARD Medical Publishes Closing of Bookbuild Offering
October 28, 2025
ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase
October 24, 2025
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million
October 22, 2025
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
October 13, 2025
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWA...
September 18, 2025
ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe
September 8, 2025
ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025
September 2, 2025
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
August 18, 2025
ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors
August 6, 2025
ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors
July 7, 2025
ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application
July 1, 2025
ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025
June 17, 2025
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders
June 11, 2025
ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights
June 11, 2025
ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants
May 21, 2025
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions
April 30, 2025
ONWARD Medical Announces Release of 2024 Annual Report
April 28, 2025
ONWARD Medical Establishes US ADR Program and Begins Trading on OTCQX Best Market
April 24, 2025